<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Modern Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Modern Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Современная онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1815-1434</issn><issn publication-format="electronic">1815-1442</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">109094</article-id><article-id pub-id-type="doi">10.26442/18151434.2022.4.201786</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL ONCOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ОНКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The NETosis phenomena as a functional features of peripheral blood neutrophils and its role in the pathogenesis of infections and oncological diseases: A review</article-title><trans-title-group xml:lang="ru"><trans-title>Феномен НЕТоза как функциональная особенность нейтрофилов периферической крови и его возможная роль в патогенезе инфекционных и онкологических заболеваний</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4122-1569</contrib-id><contrib-id contrib-id-type="scopus">1069449</contrib-id><contrib-id contrib-id-type="spin">6093-0578</contrib-id><name-alternatives><name xml:lang="en"><surname>Glukhareva</surname><given-names>Anastasia E.</given-names></name><name xml:lang="ru"><surname>Глухарева</surname><given-names>Анастасия Евгеньевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Clinical Resident</p></bio><bio xml:lang="ru"><p>клин. ординатор, лаборант исследователь</p></bio><email>gluharevaa78@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7128-2397</contrib-id><contrib-id contrib-id-type="scopus">896307</contrib-id><contrib-id contrib-id-type="researcherid">О-3150-2017</contrib-id><contrib-id contrib-id-type="spin">9039-6110</contrib-id><name-alternatives><name xml:lang="en"><surname>Afonin</surname><given-names>Grigory V.</given-names></name><name xml:lang="ru"><surname>Афонин</surname><given-names>Григорий Владиславович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, ст. науч. сотр. отд-ния лучевого и хирургического лечения заболеваний торакальной области</p></bio><email>Dr.G.Afonin@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7229-2813</contrib-id><contrib-id contrib-id-type="scopus">1118349</contrib-id><contrib-id contrib-id-type="spin">4197-1929</contrib-id><name-alternatives><name xml:lang="en"><surname>Melnikova</surname><given-names>Angelika A.</given-names></name><name xml:lang="ru"><surname>Мельникова</surname><given-names>Анжелика Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Res. Officer</p></bio><bio xml:lang="ru"><p>науч. сотр. отд-ния клин. иммунологии</p></bio><email>angelik_melnikova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9103-9688</contrib-id><contrib-id contrib-id-type="scopus">583894</contrib-id><contrib-id contrib-id-type="spin">4423-6844</contrib-id><name-alternatives><name xml:lang="en"><surname>Grivtsova</surname><given-names>Lyudmila Yu.</given-names></name><name xml:lang="ru"><surname>Гривцова</surname><given-names>Людмила Юрьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>д-р биол. наук, зав. отд-нием клин. иммунологии</p></bio><email>grivtsova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3573-6996</contrib-id><contrib-id contrib-id-type="scopus">878091</contrib-id><contrib-id contrib-id-type="spin">1382-5529</contrib-id><name-alternatives><name xml:lang="en"><surname>Kolobaev</surname><given-names>Ilya V.</given-names></name><name xml:lang="ru"><surname>Колобаев</surname><given-names>Илья Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, зав. отд-нием лучевого и хирургического лечения заболеваний торакальной области</p></bio><email>kolobaeviv@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7689-6032</contrib-id><contrib-id contrib-id-type="scopus">16070399200</contrib-id><contrib-id contrib-id-type="researcherid">N-8221-2017</contrib-id><contrib-id contrib-id-type="spin">4264-5167</contrib-id><name-alternatives><name xml:lang="en"><surname>Ivanov</surname><given-names>Sergei A.</given-names></name><name xml:lang="ru"><surname>Иванов</surname><given-names>Сергей Анатольевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof. RAS</p></bio><bio xml:lang="ru"><p>проф. РАН, д-р мед. наук, дир.</p></bio><email>gluharevaa78@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8784-8415</contrib-id><contrib-id contrib-id-type="scopus">96775</contrib-id><contrib-id contrib-id-type="spin">1759-8101</contrib-id><name-alternatives><name xml:lang="en"><surname>Kaprin</surname><given-names>Andrei D.</given-names></name><name xml:lang="ru"><surname>Каприн</surname><given-names>Андрей Дмитриевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Acad. RAS</p></bio><bio xml:lang="ru"><p>акад. РАН, д-р мед. наук, проф., ген. дир., зав. каф. урологии и оперативной нефрологии с курсом онкоурологии медицинского института</p></bio><email>gluharevaa78@gmail.com</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Center</institution></aff><aff><institution xml:lang="ru">Медицинский радиологический научный центр им. А.Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">National Medical Research Radiological Center</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">People’s Friendship University of Russia (RUDN University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский университет дружбы народов»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2022</year></pub-date><volume>24</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>487</fpage><lpage>493</lpage><history><date date-type="received" iso-8601-date="2022-07-07"><day>07</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://modernonco.orscience.ru/1815-1434/article/view/109094">https://modernonco.orscience.ru/1815-1434/article/view/109094</self-uri><abstract xml:lang="en"><p>The review is devoted to the analysis of the mechanism of NETosis and the formation of extracellular traps by neutrophils. Neutrophil traps are DNA strands, histones and proteins that are involved in autoimmune diseases, COVID-19, as well as in the pathogenesis of other non-communicable diseases. Based on the literature data, the role of NETosis in the development oncological diseases is analyzed. Two types of neutrophils have been characterized: low-density neutrophils and high-density neutrophils. In particular, the significance of this phenomenon in the progression and metastasis of the cancer. A detailed study of this issue will be useful both from a fundamental standpoint regarding the disclosure of the mechanisms of the metastatic cascade, and from a practical point of view for the development of new immunotherapeutic approaches in the treatment of metastatic tumors.</p></abstract><trans-abstract xml:lang="ru"><p>В обзоре рассматривается особый механизм противоинфекционной защиты нейтрофилов – НЕТоз, заключающийся в формировании нейтрофильных внеклеточных ловушек (НВЛ), представляющих собой нити ДНК, гистоны и белки. Описывается роль НВЛ в аутоиммунных заболеваниях, COVID-19, а также в патогенезе других неинфекционных заболеваний. На основании данных литературы проанализированы роль НВЛ в развитии и течении онкологических заболеваний и значимость данного феномена в отношении метастазирования и прогрессии опухолевого процесса. Охарактеризованы два типа нейтрофилов: нейтрофилы низкой плотности и нейтрофилы высокой плотности. Детальное изучение данного вопроса будет полезным как с фундаментальных позиций в первую очередь для детализации механизмов метастатического каскада опухолей, так и с практической точки зрения для разработки новых иммунотерапевтических подходов в отношении метастатических опухолей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>neutrophil extracellular traps</kwd><kwd>low and high density neutrophils</kwd><kwd>oncological diseases</kwd><kwd>NETosis</kwd><kwd>COVID-19</kwd><kwd>lung diseases</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нейтрофильные внеклеточные ловушки</kwd><kwd>нейтрофилы низкой и высокой плотности</kwd><kwd>онкологические заболевания</kwd><kwd>НЕТоз</kwd><kwd>COVID-19</kwd><kwd>заболевания легких</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Потапнев М.П., Гущина Л.М., Мороз Л.А. Фенотипическая и функциональная гетерогенность субпопуляций нейтрофилов в норме и при патологии. Иммунология. 2019;40(5):84-96 [Potapnev MP, Gushchina LM, Moroz LA. Phenotypic and functional heterogeneity of neutrophil subpopulations in normal and pathological conditions. Immunology. 2019;40(5):84-96 (in Russian)]. DOI:10.24411/ 0206-4952-2019-15009</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532-5. DOI:10.1126/science.1092385</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231-41. DOI:10.1083/jcb.200606027</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Палладина А.Д., Хомякова Н.Ф. Нетоз как механизм прогрессирования рака. Иммунология гемопоэза. 2019;17(2):39-52 [Palladina AD, Khomyakova NF. NETosis as a mechanism of cancer progression. Immunology of hematopoiesis. 2019;17(2):39-52 (in Russian)].</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Воробьева Н.В., Черняк Б.В. Нетоз: молекулярные механизмы, роль в физиологии и патологии. Биохимия. 2020;85(10):1383-97 [Vorobyova NV, Chernyak BV. NETosis: molecular mechanisms, role in physiology and pathology. Biochemistry. 2020;85(10):1383-97 (in Russian)]. DOI:10.31857/S0320972520100061</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Steinberg SF. Mechanisms for redox-regulation of protein kinase C. Front Pharmacol. 2015;6:128. DOI:10.3389/ fphar.2015.00128</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Vorobjeva N, Prikhodko A, Galkin I, et al. Mitochondrial reactive oxygen species are involved in chemoattractant-induced oxidative burst and degranula-tion of human neutrophils in vitro. Eur J Cell Biol. 2017;96(3):254-65. DOI:10.1016/j.ejcb.2017.03.003</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Douda DN, Khan MA, Grasemann H, et al. SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx. Proc Natl Acad Sci U S A. 2015;112(9):2817-22. DOI:10.1073/pnas.1414055112</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ravindran M, Khan MA, Palaniyar N. Neutrophil Extracellular Trap Formation: Physiology, Pathology, and Pharmacology. Biomolecules. 2019;9(8):365. DOI:10.3390/biom9080365</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Vorobjeva N, Galkin I, Pletjushkina O, et al. Mitochondrial permeability transition pore is involved in oxidative burst and NETosis of human neutrophils. Biochim Biophys Acta Mol Basis Dis. 2020;1866(5):165664. DOI:10.1016/j.bbadis.2020.165664</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Metzler KD, Goosmann C, Lubojemska A, et al. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell. Rep. 2014;8(3):883-96. DOI:10.1016/j.celrep.2014.06.044</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Chen KW, Monteleone M, Boucher D, et al. Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps. Sci Immunol. 2018;3(26):eaar6676. DOI:10.1126/sciimmunol.aar6676</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>D’Cruz AA, Speir M, Bliss-Moreau M, et al. The pseudokinase MLKL activates PAD4-dependent NET formation in necroptotic neutrophils. Sci Signal. 2018;11(546):eaao1716. DOI:10.1126/scisignal.aao1716</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rada B, Leto TL. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol. 2008;15:164-87. DOI:10.1159/000136357</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Li P, Li M, Lindberg MR, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853-62. DOI:10.1084/jem.20100239</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Demers M, Krause DS, Schatzberg D, et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A. 2012;109(32):13076-81. DOI:10.1073/pnas.1200419109</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yaqinuddin A, Kashir J. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop. Med Hypotheses. 2020;143:109906. DOI:10.1016/j.mehy.2020.109906</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. AdvBiolRegul. 2020;77:100741. DOI:10.1016/j.jbior.2020.100741</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Abakumova TV, Gening TP, Dolgova DR, et al. Influence of the levels of the pro-inflammatory cytokines on the formation of extracellular neutrophilic traps in disseminated ovarian cancer. Russian Journal of Immunology. 2019;22(2-2):704-6. DOI:10.31857/S102872210006765-6</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. DOI:10.1084/jem.20200652</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Jin X, Zhao Y, Zhang F, et al. Neutrophil extracellular traps involvement in corneal fungal infection. Mol Vis. 2016;22:944-52.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Hwang JW, Kim JH, Kim HJ, et al. Neutrophil extracellular traps in nasal secretions of patients with stable and exacerbated chronic rhinosinusitis and their contribution to induce chemokine secretion and strengthen the epithelial barrier. ClinExpAllergy. 2019;49(10):1306-20. DOI:10.1111/cea.13448</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Sollberger G, Tilley DO, Zychlinsky A. Neutrophil Extracellular Traps: The Biology of Chromatin Externalization. Dev Cell. 2018;44(5):542-53. DOI:10.1016/j.devcel.2018.01.01</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Twaddell SH, Baines KJ, Grainge C, et al. The Emerging Role of Neutrophil Extracellular Traps in Respiratory Disease. Chest. 2019;156(4):774-82. DOI:10.1016/j.chest.2019.06.012.8</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Dicker AJ, Crichton ML, Pumphrey EG, et al. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141(1):117-27. DOI:10.1016/j.jaci.2017.04.022</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Uddin M, Watz H, Malmgren A, Pedersen F. NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma. Front Immunol. 2019;10:47. DOI:10.3389/fimmu.2019.00047</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Chen L, Zhao Y, Lai D, et al. Neutrophil extracellular traps promote macrophage pyroptosis in sepsis. Cell Death Dis. 2018;9(6):597. DOI:10.1038/s41419-018-0538-5</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Ivanov I, Shakhawat R, Sun M, et al. Nucleic acids as cofactors for factor XI and prekallikreinactivation: Different roles for high-molecular-weight kininogen. Thromb Haemost. 2017;117(4):671-81. DOI:10.1160/TH16-09-0691</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Noubouossie D, Whelihan M, Yu YB, et al. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood. 2017;129(8):1021-9. DOI:10.1182/blood-2016-06-722298</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Okeke EB, Louttit C, Fry C, et al. Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock. Biomaterials. 2020;238:119836. DOI:10.1016/j.biomaterials.2020.119836</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Novotny J, Oberdieck P, Titova A, et al. Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction. Neurology. 2020;94(22):e2346-60. DOI:10.1212/WNL.0000000000009532</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Айтбаев К.А., Муркамилов И.Т., Фомин В.В., и др. Коронавирусная болезнь 2019 (COVID-19): нетоз-ассоциированные механизмы прогрессирования и перспективы терапии, регулирующей образование нейтрофильныхвнеклекточных ловушек (NETs). Actabiomedicascientifica. 2021;6(4):64-73 [Aitbayev KA, Murkamilov IT, Fomin VV, et al. Coronavirus disease 2019 (COVID-19): not a toz- not a pelvis regulating the formation of neutrophilic entrapment traps (nets). Actabiomedicascientifica. 2021;6(4):64-73 (in Russian)]. DOI:10.29413/ABS.2021-6.4.6</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Grieshaber-Bouyer R, Nigrovic PA. Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease. Front Immunol. 2019;10:346. DOI:10.3389/fimmu.2019.00346</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Chatfield SM, Thieblemont N, Witko-Sarsat V. Expanding Neutrophil Horizons: New Concepts in Inflammation. J Innate Immun. 2018;10(5-6):422-31. DOI:10.1159/000493101</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Fousert E, Toes R, Desai J. Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses. Cells. 2020;9(4):915. DOI:10.3390/cells9040915</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Wolach O, Sellar RS, Martinod K, et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med. 2018;10(436):eaan8292. DOI:10.1126/scitranslmed.aan8292</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Cabrini M, Nahmod K, Geffner J. New insights into the mechanisms controlling neutrophil survival. Curr Opin Hematol. 2010;17(1):31-5. DOI:10.1097/MOH.0b013e3283333b29</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>von Köckritz-Blickwede M, Nizet V. Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med (Berl). 2009;87(8):775-83. DOI:10.1007/s00109-009-0481-0</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Yost CC, Cody MJ, Harris ES, et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood. 2009;113(25):6419-27. DOI:10.1182/blood-2008-07-171629</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Liew PX, Kubes P. The Neutrophil's Role During Health and Disease. Physiol Rev. 2019;99(2):1223-48. DOI:10.1152/physrev.00012.2018</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14(1):173. DOI:10.1186/s13045-021-01187-y</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Jaillon S, Ponzetta A, Di Mitri D, et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020;20(9):485-503. DOI:10.1038/s41568-020-0281-y</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Sagiv JY, Michaeli J, Assi S, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10(4):562-73. DOI:10.1016/j.celrep.2014.12.039</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Rocks N, Vanwinge C, Radermecker C, et al. Ozone-primed neutrophils promote early steps of tumour cell metastasis to lungs by enhancing their NET production. Thorax. 2019;74(8):768-79. DOI:10.1136/thoraxjnl-2018-211990</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Albrengues J, Shields MA, Ng D, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361(6409):eaao4227. DOI:10.1126/science.aao4227</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Berger-Achituv S, Brinkmann V, Abed UA, et al. A proposed role for neutrophil extracellular traps in cancer immunoediting. Front Immunol. 2013;4:48. DOI:10.3389/fimmu.2013.00048</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Oklu R, Sheth RA, Wong KHK, et al. Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S140-9. DOI:10.21037/cdt.2017.08.01</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Hsu BE, Tabariès S, Johnson RM, et al. Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis. Cell Rep. 2019;27(13):3902-15.e6. DOI:10.1016/j.celrep.2019.05.091</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Grilz E, Mauracher LM, Posch F, et al. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer. Br J Haematol. 2019;186(2):311-20. DOI:10.1111/bjh.15906</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Park J, Wysocki RW, Amoozgar Z, et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016;8(361):361ra138. DOI:10.1126/scitranslmed.aag1711</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Vorobjeva NV, Pinegin BV. Neutrophil extracellular traps: mechanisms of formation and role in health and disease. Biochemistry (Mosc). 2014;9(12):1286-96. DOI:10.1134/S0006297914120025</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Lewis HD, Liddle J, Coote JE, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015;11(3):189-91. DOI:10.1038/nchembio.1735</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Volkov DV, Tetz GV, Rubtsov YP, et al. Neutrophil Extracellular Traps (NETs): Opportunities for Targeted Therapy. Acta Naturae. 2021;13(3):15-23. DOI:10.32607/actanaturae.11503</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Гусев С.А., Басырева Л.Ю., Максимов Д.И., и др. Витамин D3 блокирует образование нейтрофильных внеклеточных ловушек в цельной крови. Молекулярные, мембранные и клеточные основы функционирования биосистем: Тезисы докладов международной научной конференции, Четырнадцатого съезда Белорусского общественного объединения фотобиологов и биофизиков, Минск, 17–19 июня 2020 года. Минск: Белорусский государственный университет, 2020; c. 114 [Gusev SA, Batyreva LYu, Maksimov DI, et al. Vitamin D3 blokiruet obrazovanie neitrofil'nykh vnekletochnykh lovushek v tsel'noi krovi. Molekuliarnye, membrannye i kletochnye osnovy funktsionirovaniia biosistem: Tezisy dokladov mezhdunarodnoi nauchnoi konferentsii, Chetyrnadtsatogo s"ezda Belorusskogo obshchestvennogo ob"edineniia fotobiologov i biofizikov, Minsk, 17–19 iiunia 2020 goda. Minsk: Belarusian State University, 2020; p. 114 (in Russian)].</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Пинегин Б.В., Дагиль Ю.А., Воробьева Н.В., и др. Влияние азоксимера бромида на формирование внеклеточных нейтрофильных ловушек. РМЖ. 2019;1:1-6 [Pinegin BV, Dogel YuA, Vorobyova NV, et al. The effect of azoximer bromide on the formation of extracellular neutrophil traps. Breast cancer. 2019;1:1-6 (in Russian)].</mixed-citation></ref></ref-list></back></article>
